Paisalo Digital Limited (LUX:SEINV)

Intra-Cellular Therapies Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	-	2,001	1,790	936.19	792.51	579.8
Depreciation & Amortization	-	42.7	30.05	24.4	19.63	20.66
Other Amortization	-	12.02	3.95	8.51	12.71	16.75
Loss (Gain) From Sale of Investments	-	254.92	107.59	542.67	546.35	537.16
Change in Other Net Operating Assets	-	-10,723	-7,526	-6,014	-5,308	-2,161
Other Operating Activities	-	-6.4	-102.69	-18.99	-26.7	27.82
Operating Cash Flow	-	-8,418	-5,698	-4,522	-3,964	-978.87
Capital Expenditures	-	-127.79	-37.4	-62.57	-13.12	-0.72
Sale of Property, Plant & Equipment	-	1	1.23	11.83	0.05	-
Investment in Securities	-	-	62.19	-	-17.77	-
Investing Cash Flow	-	-126.79	26.02	-50.74	-30.84	-0.72
Long-Term Debt Issued	-	9,905	5,437	4,431	3,544	1,474
Total Debt Issued	-	9,905	5,437	4,431	3,544	1,474
Long-Term Debt Repaid	-	-810	-	-	-252.59	-784.73
Total Debt Repaid	-	-810	-	-	-252.59	-784.73
Net Debt Issued (Repaid)	-	9,095	5,437	4,431	3,291	689.71
Issuance of Common Stock	-	185.08	-	523.46	856.58	460.01
Common Dividends Paid	-	-89.65	-44.78	-44.82	-42.29	-42.29
Total Dividends Paid	-	-89.65	-44.78	-44.82	-42.29	-42.29
Other Financing Activities	-	256.6	134.37	-150	-485.27	-
Financing Cash Flow	-	9,447	5,526	4,760	3,620	1,107
Net Cash Flow	-	902.33	-145.34	187.69	-374.37	127.84
Free Cash Flow	-	-8,546	-5,735	-4,584	-3,977	-979.59
Free Cash Flow Margin	-	-204.80%	-152.16%	-217.66%	-259.13%	-75.15%
Free Cash Flow Per Share	-	-9.52	-6.20	-5.15	-4.70	-1.16
Cash Interest Paid	-	3,283	2,701	2,087	1,841	1,620
Cash Income Tax Paid	-	688.59	724.68	345.09	305.41	170.05

Updated Feb 4, 2025. Source: S&P Global Market Intelligence. Financial Services template. Financial Sources.